Therapeutisches Vorgehen bei schwerer Präeklampsie und beim HELLP-Syndrom

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Zentralblatt für Gynäkologie

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2004-820420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of preeclampsia remote from term

  2004cited by this paper
• Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis

  2003cited by this paper
• Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndrome

  2003cited by this paper
• Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis.

  2002cited by this paper
• Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.

  2002cited by this paper
• Calcium channel blockers in the management of preterm labor and hypertension in pregnancy.

  2001cited by this paper
• Anticonvulsants for women with pre-eclampsia.

  2000cited by this paper
• A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre‐eclampsia

  1998cited by this paper
• Aggressives versus konservatives Vorgehen beim HELLP-Syndrom - eine Standortbestimmung*

  1996cited by this paper
• Eclampsia in the United Kingdom

  1994cited by this paper

• CARDIOVASCULAR RISK IN WOMEN WITH PREECLAMPSIA

  2022cites this paper
• Plasmaféresis en síndrome Hellp: reporte de un caso y revisión de la literatura

  2022cites this paper
• Can Endothelial Glycocalyx Be a Major Morphological Substrate in Pre-Eclampsia?

  2020cites this paper
• Die Bedeutung der Indolamin-2,3-Dioxygenase (IDO) in der Plazenta bei Präeklampsie und HELLP-Syndrom

  2016cites this paper
• Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013)

  2015cites this paper
• Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen. Leitlinie der DGGG (S1-Level, AWMF-Registernummer 015/018, Dezember 2013)

  2015cites this paper
• Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series.

  2011cites this paper
• Oocyte Donation: A Risk Factor for Pregnancy-Induced Hypertension

  2011cites this paper
• Präeklampsie: aktuelles Management

  2008cites this paper
• Expression of E-cadherin and its repressor Snail in placental tissue of normal, preeclamptic and HELLP pregnancies

  2007cites this paper
• Oncotic therapy in management of preeclampsia.

  2006cites this paper
• Expression of estrogen receptor-α, estrogen receptor-β and placental endothelial and inducible NO synthase in intrauterine growth-restricted and normal placentas

  2006cites this paper